Fact CheckerSign in

NCT05510661Active, not recruiting

Use of Export in Primary Percutaneous Coronary Intervention

Use of Export in Primary Percutaneous Coronary Intervention, In-Hospital and Short-term Outcomes and Optimal Time of Export

Source: ClinicalTrials.gov · Last updated 9 Apr 2026

Brief summary (registry, in English)

Aim of this single center randomized open label trial with blinded in-hospital outcomes assessment is designed with aim to compare manual thrombus aspiration followed by percutaneous coronary intervention (PCI) strategy with PCI alone.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
300 (estimated)
First submitted
30 Jun 2021
Start date
15 Jan 2024
Primary completion date
24 Sept 2025
Lead sponsor
National Institute of Cardiovascular Diseases, Pakistan
NCT number
NCT05510661

What you commit to

  • Study type: Interventional
  • Planned participants: 300
  • From 15 Jan 2024 to the primary completion date, 24 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with prior history of cardiac related surgery or intervention

Other illness

  • Known existence of a disease resulting in a life expectancy of less than 6 months

Other

  • Performance of a rescue PCI after thrombolysis
  • Killip class III, IV

Who the study is looking for

  • Patients presenting with:-Symptoms of myocardial ischemia lasting for ≥30 minutes
  • Definite ECG changes indicating STEMI: ST elevation of greater than 0.1 mV in two contiguous limb leads or 0.2 mV in two contiguous precordial leads
  • Chest pain \< 12 hours duration
  • Total occlusion (TIMI 0 flow)
  • Patients undergoing primary PCI
  • Informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Institute of Cardiovascular Diseases
Coordinator of this site? Confirm its status
KarachiPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.